当前位置： SCI文献检索 > Human Vaccines & Immunotherapeutics期刊下所有文献 > Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.

Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.

Abstract：

:Liguria, an administrative region in northern Italy characterized by a decade of high PCV coverage in paediatric age group, has issued new PCV13 recommendations for free active immunization in adults with risk factors and subjects aged ≥ 70 years old. Main aims of this study are: (1) a descriptive epidemiology of the clinical burden of lower respiratory tract infections (LRTI) in adults ≥18 years of age; and (2) a crossover evaluation of the effect of introduction of PCV13 vaccination in adults aged ≥70 years old, in terms of ED accesses for LRTI, obtained by a Syndrome Surveillance System (SSS). The ED access, chief complaint based SSS will allow an active surveillance of a population cohort of >430 000 individuals resident in Genoa metropolitan area, aged ≥18 years old, for a period of 60 months. During pre-PCV period, annual cumulative incidence of ED accesses for LRTI was equal to 7/1000 and 2% in ≥65 and ≥85 year adults, respectively. In ≥65 years adults, more than 70% of subjects identified by the SSS has at least one risk condition, with a peak of 87% in ≥85 year cohort. New Ligurian PCV13 recommendations can potentially reach more than 75% of ED accesses for LRTI. Data highlights the heavy impact of LRTI in terms of ED accesses, especially in the elderly and subjects with chronic conditions and the usefulness of SSS tool for monitoring PCV vaccination effect.

journal_name

Hum Vaccin Immunother

journal_title

Human vaccines & immunotherapeutics

authors

Ansaldi F,Orsi A,Trucchi C,De Florentiis D,Ceravolo A,Coppelli M,Schiaffino S,Turello V,Rosselli R,Carloni R,Icardi G,Study Group LP,Canepa P,Sticchi L,Zanetti R,Cremonesi I,Brasesco P,Moscatelli P

doi

10.4161/hv.34419

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

166-71

issue

1

eissn

2164-5515

issn

2164-554X

journal_volume

11

pub_type

杂志文章

相关文献

Human Vaccines & Immunotherapeutics文献大全
  • Vaccines in pregnancy: The dual benefit for pregnant women and infants.

    abstract：:Maternal immunization has the potential to reduce the burden of infectious diseases in the pregnant woman and her infant. Many countries now recommend immunization against influenza at any stage of pregnancy and against pertussis in the third trimester. Despite evidence of the safety and effectiveness of these vaccine...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1127485

    authors： Marshall H,McMillan M,Andrews RM,Macartney K,Edwards K

    更新日期：2016-04-02 00:00:00

  • Maternal and infant outcomes among women vaccinated against pertussis during pregnancy.

    abstract：:Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination is recommended for all women during each pregnancy to prevent pertussis in young infants. However, data on the safety of this protective measure are limited and conflicting. To assess maternal and infant outcomes associated with administration of this vac...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1157241

    authors： Berenson AB,Hirth JM,Rahman M,Laz TH,Rupp RE,Sarpong KO

    更新日期：2016-08-02 00:00:00

  • HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study.

    abstract：BACKGROUND:Adolescents are the primary target population for human papillomavirus (HPV) vaccination. The objective of this study is to explore the acceptability of HPV vaccines and evaluate factors related to willingness to be vaccinated among Chinese adolescents. METHODS:A nation-wide survey was conducted across 14 s...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1812314

    authors： Zhang X,Wang Z,Ren Z,Li Z,Ma W,Gao X,Zhang R,Qiao Y,Li J

    更新日期：2020-10-29 00:00:00

  • Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014-2015 influenza vaccine?

    abstract：BACKGROUND:Vitamin D is an immunomodulating hormone, which has been associated with susceptibility to infectious diseases. METHODS:Serum vitamin D levels in 135 children ages 3-17 y were measured at baseline and hemagglutinin influenza antibody titers were measured pre- and 21 d post influenza vaccination with live at...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1299837

    authors： Lin CJ,Martin JM,Cole KS,Zimmerman RK,Susick M,Moehling KK,Levine MZ,Spencer S,Flannery B,Nowalk MP

    更新日期：2017-07-03 00:00:00

  • Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.

    abstract：:One combined measles-mumps-rubella (MMR) vaccine without Human Serum Albumin (HSA) is currently licensed in the USA (M-M-R II; Merck, USA) and another has been developed (Priorix™ [MMR-RIT, GSK, Belgium]). In this follow-up study, children from USA or Puerto Rico, who had received one dose of M-M-R II or MMR-RIT at 12...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1080/21645515.2017.1309486

    authors： Berry AA,Abu-Elyazeed R,Diaz-Perez C,Mufson MA,Harrison CJ,Leonardi M,Twiggs JD,Peltier C,Grogg S,Carbayo A,Shapiro S,Povey M,Baccarini C,Innis BL,Henry O

    更新日期：2017-07-03 00:00:00

  • Key considerations for successful implementation of maternal immunization programs in low and middle income countries.

    abstract：:The Maternal Neonatal Tetanus Elimination program is proof of concept for the feasibility and potential for maternal immunization to reduce neonatal mortality particularly in low and middle-income countries. Introduction of any additional vaccine into the antenatal space, such as Influenza and Pertussis, and potential...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2018.1564433

    authors： Krishnaswamy S,Lambach P,Giles ML

    更新日期：2019-01-01 00:00:00

  • Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine.

    abstract：:Timely vaccine supply is critical during influenza pandemics but is impeded by current virus-based manufacturing methods. The 2009 H1N1/2009pdm 'swine flu' pandemic reinforced the need for innovation in pandemic vaccine design. We report on insights gained during rapid development of a pandemic vaccine based on recomb...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1080/21645515.2017.1279765

    authors： Honda-Okubo Y,Rajapaksha H,Sajkov D,Gordon D,Cox MMJ,Petrovsky N

    更新日期：2017-06-03 00:00:00

  • Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

    abstract：:Pandemic outbreaks of influenza type A viruses have resulted in numerous fatalities around the globe. Since the conventional influenza vaccines (CIV) provide less than 20% protection for individuals with weak immune system, it has been considered that broadly cross-neutralizing antibodies may provide a better protecti...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1403703

    authors： Mendoza M,Ballesteros A,Qiu Q,Pow Sang L,Shashikumar S,Casares S,Brumeanu TD

    更新日期：2018-02-01 00:00:00

  • Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.

    abstract：:There is a need for both new and improved vaccination formulations for a range of diseases for which current vaccines are either inadequate or non-existent. Biodegradable polymer-based vaccines fulfill many of the desired properties in achieving effective long-term protection in a manner that is safe, economical, and ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.26136

    authors： Joshi VB,Geary SM,Salem AK

    更新日期：2013-12-01 00:00:00

  • Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count.

    abstract：:HIV-infected patients are 30- to 100-fold more susceptible to invasive pneumococcal diseases than are healthy adults. Pneumococcal vaccination may be the best way to decrease the large pneumococcal disease burden, but the optimal timing of vaccination is still unclear. In this study, HIV-infected subjects aged ≥18 yea...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1643677

    authors： Song JY,Cheong HJ,Noh JY,Choi MJ,Yoon JG,Kim WJ

    更新日期：2020-01-01 00:00:00

  • Coverage of HPV-Related Information on Chinese Social Media: a Content Analysis of Articles in Zhihu.

    abstract：:Information about human papillomavirus (HPV) disease and its vaccination has been increasingly communicated and discussed on social media platforms. The current study aims to investigate the coverage of HPV-related information on one of the most popular Chinese social media - Zhihu. Data for this study were user-gener...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1729028

    authors： Li J,Zheng H

    更新日期：2020-10-02 00:00:00

  • Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients.

    abstract：:Both our research and that published by Sticchi et al. on immunological memory against hepatitis B virus (HBV) in health-care workers (HCWs) vaccinated as infants or adolescents confirm that in those testing negative after the primary course, one additional (fourth) booster dose is able to elicit an anti-HBs response ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1810495

    authors： Bechini A,Bonanni P,Grazzini M,Paolini D,Arcangeli G,Mucci N,Bini C,Tiscione E,Zanella B,Boccalini S

    更新日期：2020-12-03 00:00:00

  • Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study).

    abstract：BACKGROUND:Febrile seizure is the most common childhood neurological disorder, is an important health problem with potential short- and long-term complications, also leading to economic burden and increased parental anxiety about fevers and seizures occurring in their children. There are no routine recommendation to de...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,多中心研究

    doi：10.1080/21645515.2018.1526588

    authors： Carman KB,Calik M,Karal Y,Isikay S,Kocak O,Ozcelik A,Yazar AS,Nuhoglu C,Sag C,Kilic O,Dinleyici M,Lacinel Gurlevik S,Yimenicioglu S,Ekici A,Perk P,Tosun A,Isik I,Yarar C,Arslantas D,Dinleyici EC

    更新日期：2019-01-01 00:00:00

  • Parents' attitude toward multiple vaccinations at a single visit with alternative delivery methods.

    abstract：:Last decades, the number of routine childhood vaccinations has increased considerably, which consequently has led to multiple vaccine injections per consultation. Implementation of additional vaccines will probably lead to more than 2 vaccine injections per consult, which might be a barrier for parents to vaccinate th...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.29361

    authors： Kaaijk P,Kleijne DE,Knol MJ,Harmsen IA,Ophorst OJ,Rots NY

    更新日期：2014-01-01 00:00:00

  • Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.

    abstract：:Influenza vaccination is the most effective way of preventing influenza infections but its coverage is extremely low in China. Poor influenza vaccine effectiveness (VE) was reported in the 2014/15 season in some Northern Hemisphere countries with a predominance of H3N2 viruses belonging to the 3C.2a clade. However, th...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1359364

    authors： Ma C,Pan Y,Zhang L,Zhang Y,Wu S,Sun Y,Duan W,Zhang M,Wang Q,Yang P

    更新日期：2017-10-03 00:00:00

  • A physician's guide to the 2-dose schedule of MenB-FHbp vaccine.

    abstract：:Meningococcal serogroup B (MenB) is the predominant cause of invasive meningococcal disease in the United States, with older adolescents and young adults attending college at increased risk. Notably, MenB caused all meningococcal disease outbreaks at US colleges between 2011 and 2018. MenB disease is vaccine-preventab...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2019.1596711

    authors： McDaniel A,Dempsey A,Srivastava A

    更新日期：2019-01-01 00:00:00

  • Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis.

    abstract：:Resurgent mumps outbreaks have raised questions about the current efficacy of mumps vaccines. We have applied immunoinformatics techniques based on principal component analysis to evaluate patterns in predicted B-cell linear epitopes, MHC binding affinity and cathepsin cleavage in the hemagglutinin neuraminidase prote...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.27139

    authors： Homan EJ,Bremel RD

    更新日期：2014-01-01 00:00:00

  • Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.

    abstract：:Tuberculosis (TB) is a significant cause of illness and death worldwide. Immunotherapy has been investigated in the treatment of TB. The purpose of this study was to perform a meta-analysis investigating the effectiveness of the M. vaccae vaccine. Medline, Cochrane, EMBASE, and Google Scholar were searched until Novem...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1080/21645515.2017.1335374

    authors： Huang CY,Hsieh WY

    更新日期：2017-09-02 00:00:00

  • Antibody-mediated immunotherapy against chronic hepatitis B virus infection.

    abstract：:The currently available drugs to treat hepatitis B virus (HBV) infection include interferons and nucleos(t)ide analogs, which can only induce disease remission and are inefficient for the functional cure of patients with chronic HBV infection (CHB). Since high titers of circulating hepatitis B surface antigen (HBsAg) ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1319021

    authors： Gao Y,Zhang TY,Yuan Q,Xia NS

    更新日期：2017-08-03 00:00:00

  • Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.

    abstract：:We report the findings of three randomized, double-blind, placebo-controlled Phase I studies undertaken to support licensure of the liquid formulation of the human G1P[8] rotavirus (RV) vaccine (RIX4414; GlaxoSmithKline Biologicals SA) in China. Healthy adults aged 18-45 y (n=48) and children aged 2-6 y (n=50) receive...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/hv.25076

    authors： Li RC,Li YP,Mo ZJ,Luo D,Huang T,Kong JL,Wang LH,Song NS,Liu A,Zhang H,Liao X,Karkada N,Han HH

    更新日期：2013-08-01 00:00:00

  • Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

    abstract：:Various glycoprotein conjugate vaccines have been developed for the prevention of invasive meningococcal disease, having significant advantages over pure polysaccharide vaccines. One of the most important features of the conjugate vaccines is the induction of a T-cell dependent immune response, which enables both the ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1153206

    authors： Bröker M,Berti F,Costantino P

    更新日期：2016-07-02 00:00:00

  • Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?

    abstract：:Control programs for emerging influenza are in urgent need of novel therapeutic strategies to mitigate potentially devastating threats from pathogenic strains with pandemic potential. Current vaccines and antivirals have inherent limitations in efficacy, especially with rapid evolutionary changes of influenza viruses....

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2017.1363135

    authors： Berry CM

    更新日期：2018-03-04 00:00:00

  • A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016).

    abstract：:Higher-valent pneumococcal conjugate vaccines (PCVs) were licensed from 2009 in Europe; similar worldwide clinical effectiveness was observed for PCVs in routine use. Despite a proven medical need, PCV vaccination in Southern Europe remained suboptimal until 2015/16. We searched PubMed for manuscripts published betwee...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2016.1263409

    authors： Moreira M,Castro O,Palmieri M,Efklidou S,Castagna S,Hoet B

    更新日期：2017-06-03 00:00:00

  • Overview of the cancer vaccine field: are we moving forward?

    abstract：:Cancer immunotherapy has seen a tremendous number of failures and only few recent regulatory successes. This review is a first in a series dedicated to evaluate the status of current global clinical pipeline for cancer vaccines. Apart from specific areas of medical need which can be addressed by cancer vaccines, the a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.20474

    authors： Kudrin A,Hanna MG Jr

    更新日期：2012-08-01 00:00:00

  • A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.

    abstract：:In 1796, Edward Jenner introduced the concept of vaccination with cowpox virus, an Orthopoxvirus within the family Poxviridae that elicits cross protective immunity against related orthopoxviruses, including smallpox virus (variola virus). Over time, vaccinia virus (VACV) replaced cowpox virus as the smallpox vaccine,...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.21080

    authors： Verardi PH,Titong A,Hagen CJ

    更新日期：2012-07-01 00:00:00

  • Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.

    abstract：:The Solid Organ Transplantation (SOT) and Haematopoietic Stem Cell Transplantation (HSCT) population is continuously increasing as a result of broader indications for transplant and improved survival. Infectious diseases, including vaccine-preventable diseases, are a significant threat for this population, primarily a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1078043

    authors： L'Huillier AG,Kumar D

    更新日期：2015-01-01 00:00:00

  • Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.

    abstract：:In 2000, China was declared polio-free. However, in 2018, wild poliovirus (WPV) was still endemic in two of its neighboring countries, making WPV importation and outbreak alarming possibilities. This study documents the seroprevalence of poliovirus antibodies before and after the polio vaccine switch in 2012 and 2017 ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1778409

    authors： Li J,Zhang Z,Zhang H,Li M,Li X,Lu L,Huang F,Wu J

    更新日期：2020-07-23 00:00:00

  • Immunogenicity of pneumococcal vaccines in comorbid autoimmune and chronic respiratory diseases.

    abstract：:Streptococcus pneumoniae causes pneumonia, meningitis, otitis media, and bacteremia. The mortality and morbidity of invasive pneumococcal disease are high among adults aged >65 years or those with underlying chronic or immunosuppressive conditions. A recent systematic review showed that patients treated with immunosup...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1564443

    authors： Kuronuma K,Takahashi H

    更新日期：2019-01-01 00:00:00

  • Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study.

    abstract：:In Japan, government support for human papillomavirus (HPV) vaccination began in November 2010. However, the mass media repeatedly reported on severe adverse events. The Japanese Ministry of Health, Labor and Welfare suspended proactive recommendations for HPV vaccines in June 2013. Japan's HPV vaccination rate droppe...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1817715

    authors： Tozawa-Ono A,Kamada M,Teramoto K,Hareyama H,Kodama S,Kasai T,Iwanari O,Koizumi T,Ozawa N,Suzuki M,Kinoshita K

    更新日期：2020-10-29 00:00:00

  • Completeness and timeliness of vaccination and determinants for low and late uptake among young children in eastern China.

    abstract：BACKGROUND:We studied completeness and timeliness of vaccination and determinants for low and delayed uptake in children born between 2008 and 2009 in Zhejiang province in eastern China. METHODS:We used data from a cross-sectional cluster survey conducted in 2011, which included 1146 children born from 1 Jan 2008 to 3...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.28054

    authors： Hu Y,Chen Y,Guo J,Tang X,Shen L

    更新日期：2014-01-01 00:00:00